Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mallinckrodt moving away from imaging agents with acquisition of Nellcor Puritan Bennett.

Executive Summary

MALLINCKRODT MOVING AWAY FROM IMAGING FOCUS WITH RESPIRATORY EQUIPMENT company Nellcor Puritan Bennett acquisition announced July 23. Seeking to breath new life into its health care products business, Mallinckrodt agreed to pay $28.50 per share for NPB stock, which closed July 23 at $20.94. Mallinckrodt will pay $1.82 bil. for NPB's approximately 63.8 mil. outstanding shares and another $70 mil. for NPB options. The acquisition has been approved by the boards of both companies.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS030589

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel